» Articles » PMID: 26993047

Adiponectin, the Past Two Decades

Overview
Journal J Mol Cell Biol
Specialty Molecular Biology
Date 2016 Mar 20
PMID 26993047
Citations 276
Authors
Affiliations
Soon will be listed here.
Abstract

Adiponectin is an adipocyte-specific factor, first described in 1995. Over the past two decades, numerous studies have elucidated the physiological functions of adiponectin in obesity, diabetes, inflammation, atherosclerosis, and cardiovascular disease. Adiponectin, elicited through cognate receptors, suppresses glucose production in the liver and enhances fatty acid oxidation in skeletal muscle, which together contribute to a beneficial metabolic action in whole body energy homeostasis. Beyond its role in metabolism, adiponectin also protects cells from apoptosis and reduces inflammation in various cell types via receptor-dependent mechanisms. Adiponectin, as a fat-derived hormone, therefore fulfills a critical role as an important messenger to communicate between adipose tissue and other organs. A better understanding of adiponectin actions, including the pros and cons, will advance our insights into basic mechanisms of metabolism and inflammation, and potentially pave the way toward novel means of pharmacological intervention to address pathophysiological changes associated with diabetes, atherosclerosis, and cardiometabolic disease.

Citing Articles

Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.

Sauter K, Webb G, Bader L, Kreklywich C, Takahashi D, Zaro C bioRxiv. 2025; .

PMID: 40027795 PMC: 11870618. DOI: 10.1101/2025.02.18.638792.


Distinguishing exocrine pancreas disease-associated diabetes from type 2 diabetes based on anthropometric and metabolic parameters.

Juza A, Kolodziej-Spirodek L, Gutkowski K, Partyka M, Dabrowski M World J Diabetes. 2025; 16(2):95102.

PMID: 39959260 PMC: 11718472. DOI: 10.4239/wjd.v16.i2.95102.


Association of inflammatory markers and multimorbidity in young adults: cross-sectional findings from the Pelotas (Brazil) birth cohort, 1993.

de Oliveira I, Correa T, Ferreira G, Nunes B, Goncalves H, Wehrmeister F Cad Saude Publica. 2025; 41(1):e00191623.

PMID: 39936780 PMC: 11805519. DOI: 10.1590/0102-311XEN191623.


Strength Training can Modulate Urinary Adipokine Levels in Healthy Young Males.

de Faria M, Barroso L, Souza-Gomes A, de Barros J, Kakehasi A, Vieira E Int J Exerc Sci. 2025; 18(2):107-118.

PMID: 39916794 PMC: 11798553. DOI: 10.70252/FXQY9475.


The secretory function of adipose tissues in metabolic regulation.

Liu Y, Qian S, Tang Y, Tang Q Life Metab. 2025; 3(2):loae003.

PMID: 39872218 PMC: 11748999. DOI: 10.1093/lifemeta/loae003.


References
1.
Schraw T, Wang Z, Halberg N, Hawkins M, Scherer P . Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology. 2008; 149(5):2270-82. PMC: 2329278. DOI: 10.1210/en.2007-1561. View

2.
Xu A, Chan K, Hoo R, Wang Y, Tan K, Zhang J . Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005; 280(18):18073-80. DOI: 10.1074/jbc.M414231200. View

3.
Wang Z, Scherer P . DsbA-L is a versatile player in adiponectin secretion. Proc Natl Acad Sci U S A. 2008; 105(47):18077-8. PMC: 2587574. DOI: 10.1073/pnas.0810027105. View

4.
Wang Y, Gao E, Tao L, Lau W, Yuan Y, Goldstein B . AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin. Circulation. 2009; 119(6):835-44. PMC: 2658653. DOI: 10.1161/CIRCULATIONAHA.108.815043. View

5.
Cheng K, Iglesias M, Lam K, Wang Y, Sweeney G, Zhu W . APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 2009; 9(5):417-27. DOI: 10.1016/j.cmet.2009.03.013. View